The Asia Pacific Antiseptics and Disinfectants market is forecasted to grow 1.75 billion by 2024 from USD 1.2 billion in 2019. The market is estimated to grow at a 7.92% CAGR from 2019 to 2024. The rise in the number of surgeries and the growing demand for antiseptics & disinfectants are fueling the growth of the market. In addition, change in government policies in favour of the poor people, especially during the COVID-19 outbreak is elevating the demand of the market.
MARKET DRIVERS
Increasing the scale of hospitals and clinics across the region along with the rising flow of patients, the rising prevalence for the surgical treatment procedures and the need to keep the instruments sterile to prevent the growth of bacteria are the primary growth driving factors to the Asia Pacific Surface Disinfectants Market. Furthermore, increasing support from government organizations through funds and also by creating awareness through campaigns is broadening the growth rate of the market in the Asia Pacific.
Awareness towards the prevention of growth of microbe in medical devices through antiseptics and disinfectants, rising focus to improve healthcare services in hospitals and clinics so as to promote the wellbeing of the patient is straight propelling the growth rate of the antiseptics and disinfectants market in this region.
MARKET RESTRAINTS
However, fluctuations in the production rate of these products in manufacturing companies are slowly impeding the demand of the market. The dearth of skilled staff in keeping surgical instruments more hygienic in rural areas is a challenging attribute for market growth. Rapid changes in the economic strategies by the government are also limiting the growth rate of the antiseptics and disinfectants market in the Asia Pacific. Lack of standardization is also hindering the demand of the market.
This report has been segmented & sub-segmented into the following categories:
Indian antiseptics and disinfectants market is playing the leading role in the APAC Antiseptics and Disinfectants market. Creating awareness through campaigns and digital media is lucratively lavishing the demand of the market. Growing geriatric population is an additional factor prompting the growth rate of the market in this country.
Following India, China is ruling with prominent shares of the market. Increasing demand to improve the healthcare infrastructure is majorly fueling the growth rate of the market. Escalating expenditure on healthcare is prompting the growth rate of the market in this country.
Antiseptics and disinfectants market has great opportunities in Japan. Growing disposable income in urban areas is one of the factors anticipated to accelerate the demand of the market. The rise in the incidences of various health disorders is propelling the growth rate of this market.
The antiseptics and disinfectants market in Australia, the rise in the number of research and development institutes is a key factor elevating the demand of the antiseptics and disinfectants market. Growing prevalence to sanitize properly in hospitals due to spread of COVID-19 is escalating the demand of the market.
In South Korea, the demand for antiseptics and disinfectants is expected to have the highest growth rate in the period 2020-2025. Rising scale of healthcare centres is greatly influencing the demand of the market. Rise in the awareness over the use of the antiseptics and disinfectants is levelling up the demand of this market.
Apart from the above, countries like Thailand, Russia and ASEAN countries to see significant growth due to the COVID-19 outbreak.
Promising companies in the APAC Antiseptics and Disinfectants Market profiled in this report are 3M Company, Abc Compounding, Advanced Sterilization Products, American Biotech Labs, Angelini Pharma Inc., Becton, Dickinson And Company, Bio-Cide International Inc., Cardinal Health and Carefusion Corp.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 End User
5.1.1 Introduction
5.1.2 Domestic User
5.1.3 Institutional User
5.1.4 Y-o-Y Growth Analysis, By End User
5.1.5 Market Attractiveness Analysis, By End User
5.1.6 Market Share Analysis, By End User
5.2 Type
5.2.1 Introduction
5.2.2 Alcohol and Aldehyde
5.2.3 Phenols and Derivatives
5.2.4 Biguanides and Amides
5.2.5 Quaternary Ammonium Compounds
5.2.6 Iodine Compounds
5.2.7 Others
5.2.8 Y-o-Y Growth Analysis, By Type
5.2.9 Market Attractiveness Analysis, By Type
5.2.10 Market Share Analysis, By Type
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By End User
6.1.3.3 By Type
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By End User
6.1.4.3 By Type
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By End User
6.1.5.3 By Type
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 3M Company
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Abc Compounding
8.3 Advanced Sterilization Products
8.4 American Biotech Labs
8.5 Angelini Pharma Inc.
8.6 Becton, Dickinson And Company
8.7 Bio-Cide International Inc.
8.8 ICardinal Health
8.9 Carefusion Corp.
8.10 Nufarm Limited
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Feb 2020
Download Sample
